Xiujun Cai
Zhejiang Chinese Medical University(CN)National Instruments (Ireland)(IE)Beijing Chao-Yang Hospital, Capital Medical University(CN)Sir Run Run Shaw Hospital(CN)Zhejiang Cancer Hospital(CN)Nanfang Hospital(CN)Siemens (United States)(US)Center for Special Minimally Invasive and Robotic Surgery(US)State Key Laboratory of Silicon MaterialsZhejiang University(CN)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Cholangiocarcinoma and Gallbladder Cancer Studies, MicroRNA in disease regulation, Pancreatic and Hepatic Oncology Research, Liver Disease Diagnosis and Treatment
Most-Cited Works
- → Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)(2020)818 cited
- → CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1(2020)555 cited
- → Targeting mutant p53 for cancer therapy: direct and indirect strategies(2021)551 cited
- → Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)(2023)404 cited
- → N6-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating β-catenin signaling(2020)318 cited
- → The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma(2020)286 cited